Gum Pharma Private Limited - Company Profile

Q: Who are the current directors of Gum Pharma Private Limited?

The current directors of Gum Pharma Private Limited are Madhav Gupta, Sanjiv Kumar.

It is a food and beverages private limited company based in New Delhi, Delhi, India, established in 2010.

2010 New Delhi, Delhi, India Active

Last Updated: December 22, 2025

About Gum Pharma Private Limited

Gum Pharma Private Limited, a active private limited company, was established on 05 January 2010 in New Delhi, Delhi, India. Engaging in bakery & confectionery products within the manufacturing sector, it holds CIN: U24232DL2010PTC197641. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹5.97 Cr.

It upholds a compliant status. Its leadership includes Madhav Gupta (Nominee Director), Sanjiv Kumar (Director). Past directors included Virender Sehgal, Carsten Krog, Holger Bagger Sorensen. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 201, Harsh Bhawan 64-65, Nehru Place, New Delhi, Delhi, 110019.

Company Details

CIN/LLPIN
U24232DL2010PTC197641
Registration Number
197641
Incorporation Date
05 January 2010
Authorized Capital
₹6.00 Cr
Paid-Up Capital
₹5.97 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 6.00 Cr as on 22-12-2025
Paid Up Capital ₹ 5.97 Cr as on 22-12-2025
Company Age 16 Year, 2 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 2.62% (FY 2022)
Profit Growth **** 21.35% (FY 2022)
Ebitda **** -10.86% (FY 2022)
Net Worth 11.68% (FY 2022)
Total Assets **** 9.59% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Gum Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Gum Pharma Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Madhav Gupta	Nominee Director	08 Apr 2010	Current
Sanjiv Kumar	Director	08 Apr 2010	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Nominee Director	30 Mar 2011	Past
Pramod Abcsdd	Nominee Director	13 Apr 2016	Past
Pramod Abcsdd	Nominee Director	13 Apr 2016	Past
Pramod Abcsdd	Director	08 Apr 2010	Past
Pramod Abcsdd	Nominee Director	12 Apr 2016	Past
Pramod Abcsdd	Key Managerial Personnel	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gum Pharma.

Gum Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.62% increase. The company also saw a substantial improvement in profitability, with a 21.35% increase in profit. The company's net worth Soared by an impressive increase of 11.68%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

2.62%

*******

Revenue from Operations

*******

-15.25%

*******

Total Assets

*******

9.59%

*******

Profit or Loss

*******

21.35%

*******

Net Worth

*******

11.68%

*******

EBITDA

*******

-10.86%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gum Pharma?

In 2022, Gum Pharma had a promoter holding of 83.74% and a public holding of 16.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gum Pharma?

Unlock and access historical data on people associated with Gum Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Gum Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gum Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gum Pharma

Recent Activity within the Organization

Annual General Meeting

Gum Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Balance Sheet

Progress on Gum Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
31 Mar 2025
Director Appointment

The activity Madhav Gupta was appointed as a Nominee Director was appointed as a Nominee Director on 08 Apr 2010 & has been associated with this company since 15 years 10 months . was completed.
08 Apr 2010
Director Appointment

Sanjiv Kumar was appointed as a Director was appointed as a Director on 08 Apr 2010 & has been associated with this company since 15 years 10 months . was recorded as a recent event.
08 Apr 2010
Company Incorporation

Progress on Gum Pharma Private Limited was registered on 05 Jan 2010 with Roc Delhi & aged 16 years 2 months as per MCA records. was documented.
05 Jan 2010

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Gum Pharma Private Limited?

The CIN of Gum Pharma Private Limited is U24232DL2010PTC197641.

Where is Gum Pharma Private Limited headquartered?

Gum Pharma Private Limited is headquartered at 201, Harsh Bhawan 64-65, Nehru Place, New Delhi, Delhi, 110019.

When was Gum Pharma Private Limited incorporated?

Gum Pharma Private Limited was incorporated on 05 January 2010.

Who are the current directors of Gum Pharma Private Limited?

The current directors of Gum Pharma Private Limited are

What is the primary industry of Gum Pharma Private Limited?

The primary industry of Gum Pharma Private Limited is Manufacturing.

Is Gum Pharma Private Limited a listed company?

Gum Pharma Private Limited is unlisted.

What is the capital structure of Gum Pharma Private Limited?

The authorized capital of Gum Pharma Private Limited is ₹6.00 Cr, and the paid-up capital is ₹5.97 Cr.

What is the compliance status of Gum Pharma Private Limited?

The compliance status of Gum Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available